← FDA Drug Approvals (Drugs@FDA)
ORIAHNN (COPACKAGED)
NDA · New Drug Application · Sponsor: ABBVIE · Approved 2020-05-29
Drug application
- FDA Application #
NDA213388- Application type
- New Drug Application
- Brand name
- ORIAHNN (COPACKAGED)
- Generic name
- ELAGOLIX AND ESTRADIOL AND NORETHISTERONE
- Active ingredients
- ELAGOLIX SODIUM,ESTRADIOL,NORETHINDRONE ACETATE; ELAGOLIX SODIUM
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- ABBVIE
- Manufacturer
- AbbVie Inc.
- First approval
- 2020-05-29
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown